0.6641
price up icon20.40%   0.1125
after-market Dopo l'orario di chiusura: .66 -0.0041 -0.62%
loading

Context Therapeutics Inc Azioni (CNTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
32.20%
0.1524
0.2247 0.2904 0.2933 0.3555
Operating Expenses
44.46%
3.9759
7.1579 6.4709 5.5856 7.0221
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
44.46%
3.9759
7.1579 6.4709 5.5856 7.0221
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
44.85%
-3.8235
-6.9332 -6.1805 -5.2924 -6.6665
Net Interest Income/Expense
32.20%
0.1524
0.2247 0.2904 0.2933 0.3555
Nonoperating Income/Loss
105.46%
0.00335
-0.0614 0.0154 -0.0122 0.00269
Income/Loss From Continuing Operations Before Tax
32.20%
0.1524
0.2247 0.2904 -5.0113 -6.3083
Income/Loss From Continuing Operations After Tax
45.82%
-3.6678
-6.7699 -5.8747 -5.0113 -6.3083
Net Income/Loss
45.82%
-3.6678
-6.7699 -5.8747 -5.0113 -6.3083
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
15.97
- 15.97 15.97 15.97
Diluted Average Shares
15.97
- 15.97 15.97 15.97
Basic Earnings Per Share
45.24%
-0.23
-0.42 -0.37 -0.31 -0.40
Diluted Earnings Per Share
45.24%
-0.23
-0.42 -0.37 -0.31 -0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):